title: Psychotropic drug interactions with valproate.
abstract: Valproate is a well-established anticonvulsant that is increasingly being employed, often in combination with other psychotropics, for its mood-stabilizing properties. This compound is metabolized by conjugation, beta-oxidation, and cytochrome P450 oxidation (CYP2C9, CYP2C19, and CYP2A6) and also acts as a broad-spectrum inhibitor of a variety of hepatic enzymes including glucoronyltransferase, epoxide hydrolase, and the CYP2C enzymes. In addition, it exhibits saturable protein binding and competes with many drugs for protein binding sites. It is therefore not surprising that valproate has been noted to interact with psychotropic medications of all classes. This article provides an overview of the noted pharmacokinetic psychotropic interactions with valproate, with a particular focus on the mechanisms of these interactions and potential clinical consequences.
authors.affiliation: Faculty of Pharmacy, University of Sydney, Sydney, NSW 2006, Australia. jfle7329@mail.usyd.edu.au
authors.forename: Jessica
authors.initials: J
authors.lastname: Fleming
authors.forename: Manoranjenni
authors.initials: M
authors.lastname: Chetty
mesh_terms: D000927:Anticonvulsants / Q000378:metabolism / Q000494:pharmacology*; D001189:Aryl Hydrocarbon Hydroxylases / Q000145:classification / Q000378:metabolism; D004347:Drug Interactions; D006801:Humans; D011619:Psychotropic Drugs / Q000145:classification / Q000378:metabolism / Q000494:pharmacology*; D014635:Valproic Acid / Q000378:metabolism / Q000494:pharmacology*
chemical_list: D000927:Anticonvulsants; D011619:Psychotropic Drugs; D014635:Valproic Acid; D001189:Aryl Hydrocarbon Hydroxylases